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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
14.05.2020 The potential 
effects of 
widespread 
community 
transmission of 
SARS-CoV-2 
infection in the 
WHO African 
Region: a 
predictive 
model 
BMJ Global 
Health | pre-
print 
 This predictive modelling study 
conducted by the WHO predicts that 
C19 will infect almost one-quarter of a 
billion people in Africa during the first 
year of the pandemic and 190,000 are 
likely to die unless immediate 
measures are taken to control the 
spread of the virus 
 Risk of exposure and transmission in 
the WHO African Region is lower than 
other areas of the world but an 
increase in hospital admissions and 
care needs and impacts on morbidity 
and mortality of other health 
conditions, will strain limited 
resources where health systems are 
not designed to mitigate against the 
implications of widespread community 
transmission of SARS-CoV-2 
 Countries in the WHO African Region 
need to expand the capacity and 
especially of primary hospitals, 
including basic emergency care 
needs, to mitigate implication of 
widespread community spread of 
SARS-CoV-2 
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Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
15.05.2020 Risk factors 
for SARS-
CoV-2 among 
patients in the 
Oxford Royal 
College of 
General 
Practitioners 
Research and 
Surveillance 
Centre 
primary care 
network: a 
cross-
sectional 
study 
The Lancet 
Infectious 
Diseases | 
Article 
 This observational study from 3802 
people tested for C19 (including 587 
positive tests) in the UK found that a 
positive SARS-CoV-2 test result within 
a primary care cohort was associated 
with similar risk factors as observed 
for severe outcomes of C19 in hospital 
settings, except for smoking 
 This study provides evidence of 
sociodemographic factors associated 
with a positive test, including 
deprivation, population density, 
ethnicity, obesity and chronic kidney 
disease 
Vaccines 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
14.05.2020 Targets of T 
cell responses 
to SARS-CoV-
2 coronavirus 
in humans 
with  COVID-
19 disease and 
unexposed 
individuals 
Cell | Article 
 Understanding adaptive immunity to 
SARS-CoV-2 will help vaccine design 
and evaluation of candidate vaccines, 
understand C19 pathogenesis and 
calibration of pandemic control 
measures 
 SARS-CoV-2-specific CD4+ T cells 
and antibody responses were 
observed in all C19 cases, and CD8+ 
T cell responses were observed in 
most  
 CD4+ T cell responses to spike, the 
main target of most vaccine efforts, 
were robust and correlated with the 
magnitude of the anti-SARS-CoV-2 
IgG and IgA titers 
 Valuable targets for candidate 
vaccine development were identified 
along with distinct specificity patterns 
between C19 cases and unexposed 
health controls 
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 SARS-CoV-2 reactive CD4+ T cells 
were detected in approx. 40 to 60% 
of unexposed individuals suggesting 
pre-existing cross-reactive T cell 
recognition between circulating 
‘common cold’ coronavirus and 
SARS-CoV-2 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
18.05.2020 Early data show Moderna Covid-19 
vaccine generates immune response 
Statnews | News Helen 
Branswell 
16.05.2020 Covid-19: Mental health services must be 
boosted to deal with “tsunami” of cases 
after lockdown 
BMJ | News Ingrid Torjesen 
15.05.2020 The sprint to solve coronavirus protein 
structures – and disarm them with drugs 
Nature | News 
feature 
Megan 
Scudellari 
15.05.2020 Reopening society and the need for real-
time assessment of COVID-19 at the 
community level 
JAMA | Viewpoint Frederick J. 
Angulo 
Lyn Finelli 
David L. 
Swerdlow 
15.05.2020 More harm than good? The net impact of 
COVID-19 policies is what matters for 
health 
CGD | Blog Damian Walker 
Y-Ling Chi 
Amanda 
Glassman 
Kalipso 
Chalkidou 
15.05.2020 Sex workers must not be forgotten in the 
COVID-19 response 
The Lancet | 
Comment 
Lucy Platt 
Jocelyn Elmes 
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Luca 
Stevenson 
Victoria Holt 
Stephen Rolles 
Rachel Stuart 
14.05.2020 Recommendations from Guatemala to 
urban municipalities responding to 
COVID-19 in low- and middle-income 
countries 
ARISE | Blog Guillermo Hegel 
Yaimie Lopez 
Kim Ozano 
14.05.2020 Integrating implementation science into 
covid-19 response and recovery 
BMJ | Editorial Lisa Hirschhorn 
Justin D Smith 
Miriam F Frisch 
Agnes 
Binagwaho 
13.05.2020 How COVID-19 is changing the world: a 
statistical perspective from international 
agencies 
World Bank | Blog Haishan Fu 
13.05.2020 How nutrition can protect people’s health 
during COVID-19 
World Bank | blog Muhammad Ali 
Pate  
Martien van 
Nieuwkoop 
12.05.2020 Waste in covid-19 research BMJ | Editorial Paul P Glasziou 
Sharon 
Sanders 
Tammy 
Hoffmann 
11.05.2020 COVID-19 and postinfection immunity JAMA | Viewpoint Robert D 
Kirkcaldy 
Brian A. King 
John T. Brooks 
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29.04.2020 We need global health systems to be 
stronger than ever: corruption is getting 
in the way 
Health Systems 
Global | Blog 
Rachel Cooper 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
May 2020 Responding to 
COVID-19 in 
Africa: Using data 
to find a balance 
Partnership 
for 
Evidence-
based 
response to 
COVID-19 
(PERC) | 
Report 
 A consortium of global public 
health organisations and private 
sector firms collected social, 
economic, epidemiological, 
population movement, and 
security data from AU Member 
States to help determine the 
acceptability, impact and 
effectiveness of public health 
and social measures for C19 
 These findings have been 
developed into actionable 
guidance for governments and 
policymakers 
 PERC is working with 
governments to mitigate 
unintended social and economic 
disruptions of interventions to 
control C19 
18.05.2020 Management of 
covid-19: A 
practical guideline 
for maternal and 
newborn health 
care providers in 
sub-Saharan 
Africa 
J Maternal-
Fetal & 
Neonatal 
Med | 
Guideline 
 This guideline prepares and 
equips clinicians working in the 
maternal and newborn sections 
in the sub-region to manage 
COVID-19 during pregnancy and 
childbirth 
 April 2020 Preserve essential 
health services 
during the COVID-
19 pandemic 
GFF | series 
country 
briefs 
 These country briefs provide 
data and guidance for policy 
makers and practitioners on 
preserving essential health care 
services in a time of crisis to help 
sustain progress achieved over 
recent years 
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Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including trials 
  Diagnosti
cs 
  Treatment
s 
  Vaccin
es 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-
CoV-2 
Diagnostic
s: 
performanc
e data 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based 
tests for 
COVID-19 
  Solidarity 
trial 
 COVID-
19 
Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford 
C19 
Governme
nt 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: 
C19 
Testing 
  COVID-
19 
Therapeuti
cs 
Accelerator 
  
Our World 
in Data 
  Singapor
e 
 Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 
5050 
  UK   Cochrane       
7 
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
       UKCDR       
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Region
al & 
Country 
Academi
c journals 
& 
Publisher
s 
Global Health 
Institutes/Centres/Funders/O
ther 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa 
CDC 
The 
Lancet 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicatio
n 
African 
Union 
NEJM LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Elsevier ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
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WHO Global 
research 
GeoPoll
: SSA 
BMJ ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell 
Press 
Johns Hopkins University 
 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academ
y of 
Science
s 
Cochran
e 
resource
s 
Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
UN Women Africa 
Evidenc
e 
Network 
PLoS CMMID Repository     
UNOCHA   Annals of 
Internal 
Medicine 
Norwegian Institute of Public 
Health 
    
UNHCR    Wiley 
Health 
Economi
cs 
Oxford Centre for Evidence-
based Medicine 
    
UNICEF    Pre-
prints 
medRxiv 
and 
bioRxiv 
 HEART     
UNESCO   SAGE 
journals 
 UKRI     
UN WFP   JAMA  Evidence Aid     
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GOARN   Bulletin 
of the 
WHO 
 NIH     
EPI-WIN           
World Bank           
Our World in 
Data 
          
COVID-19 
Narratives by 
David 
Nabarro 
          
Reliefweb           
Humanitarian 
OpenStreetM
ap Team 
          
Global 
Partnership 
for 
Sustainable 
Development 
Data 
          
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
10 
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
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Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
12 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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